A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity

Journal of Neurochemistry

Volumn , Issue , 2016, Pages 479-494

  Rogers, Jack T ^a   Venkataramani, Vivek ^b   Washburn, Cecilia ^a   Liu, Yanyan ^a   Tummala, Vinusha ^a   Jiang, Hong ^c   Smith, Ann ^d   Cahill, Catherine M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

APP; ferritin; iron retention; iron responsive element; lead toxicity; neuronal cell

Indexed keywords

AMYLOID PRECURSOR PROTEIN; FERROPORTIN 1; IRON REGULATORY PROTEIN 1;

5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL MEDIATED CYTOTOXICITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LEAD POISONING; NEUROBLASTOMA CELL LINE; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SH SY5Y CELL LINE; WESTERN BLOTTING;

EID: 84979583825     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13671     Document Type: Article

References (99)

1. Agholme L., Lindstrom T., Kagedal K., Marcusson J. and Hallbeck M. (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J. Alzheimers Dis. 20, 1069–1082.
2. Ajioka R. S., Phillips J. D. and Kushner J. P. (2006) Biosynthesis of heme in mammals. Biochim. Biophys. Acta 1763, 723–736.
3. Anderson S. A., Nizzi C. P., Chang Y. I. et al. (2013) The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab. 17, 282–290.
4. Ashok A., Rai N. K., Tripathi S. and Bandyopadhyay S. (2015) Exposure to As-, Cd-, and Pb-mixture induces Abeta, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol. Sci. 143, 64–80.
5. Ayton S., Lei P., Hare D. J. et al. (2015) Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of beta-Amyloid Precursor Protein. J. Neurosci. 35, 3591–3597.
6. Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W. and Vercellotti G. M. (1992) Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267, 18148–18153.
7. Balla J., Nath K. A., Balla G., Juckett M. B., Jacob H. S. and Vercellotti G. M. (1995) Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am. J. Physiol. 268, L321–L327.
8. Bandyopadhyay S. and Rogers J. T. (2014) Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis. Biochem. Pharmacol. 88, 486–494.
9. Bandyopadhyay S., Huang X., Cho H., Greig N. H., Youdim M. B. and Rogers J. T. (2006) Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator. J. Neural Transm. [Suppl]., 71, 237–247.
10. Bandyopadhyay S., Goldstein L. E., Lahiri D. K. and Rogers J. T. (2007) Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting alpha-Secretase as an Alternative Drug Target for Treatment of Alzheimer's Disease. Curr. Med. Chem. 14, 2848–2864.
11. Bandyopadhyay S., Cahill C., Balleidier A., Huang C., Lahiri D. K., Huang X. and Rogers J. T. (2013) Novel 5′ untranslated region directed blockers of iron-regulatory protein-1-dependent amyloid precursor protein translation: implications for Down syndrome and Alzheimer's disease. PLoS ONE 8, e65978.
12. Basha M. R., Wei W., Bakheet S. A., Benitez N., Siddiqi H. K., Ge Y. W., Lahiri D. K. and Zawia N. H. (2005) The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25, 823–829.
13. Belcher J. D., Chen C., Nguyen J. et al. (2014) Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123, 377–390.
14. Bihaqi S. W., Bahmani A., Subaiea G. M. and Zawia N. H. (2014) Infantile exposure to lead and late-age cognitive decline: relevance to AD. Alzheimers Dement. 10, 187–195.
15. Blanusa M., Varnai V. M., Piasek M. and Kostial K. (2005) Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr. Med. Chem. 12, 2771–2794.
16. Bressler J. P., Olivi L., Cheong J. H., Kim Y. and Bannona D. (2004) Divalent metal transporter 1 in lead and cadmium transport. Ann. N. Y. Acad. Sci. 1012, 142–152.
17. Breuer W., Epsztejn S. and Cabantchik Z. I. (1995a) Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J. Biol. Chem. 270, 24209–24215.
18. Breuer W., Epsztejn S., Millgram P. and Cabantchik I. Z. (1995b) Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am. J. Physiol. 268, C1354–C1361.
19. Breuer W., Ronson A., Slotki I. N., Abramov A., Hershko C. and Cabantchik Z. I. (2000) The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95, 2975–2982.
20. Carlson E. S., Tkac I., Magid R., O'Connor M. B., Andrews N. C., Schallert T., Gunshin H., Georgieff M. K. and Petryk A. (2009) Iron is essential for neuron development and memory function in mouse hippocampus. J. Nutr. 139, 672–679.
21. Cecil K. M., Brubaker C. J., Adler C. M. et al. (2008) Decreased brain volume in adults with childhood lead exposure. PLoS Med. 5, e112.
22. Cecil K. M., Dietrich K. N., Altaye M., Egelhoff J. C., Lindquist D. M., Brubaker C. J. and Lanphear B. P. (2011) Proton magnetic resonance spectroscopy in adults with childhood lead exposure. Environ. Health Perspect. 119, 403–408.
23. Cho H. H., Cahill C. M., Vanderburg C. R., Scherzer C. R., Wang B., Huang X. and Rogers J. T. (2010) Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J. Biol. Chem. 285, 31217–31232.
24. Chung J., Anderson S. A., Gwynn B. et al. (2014) Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria. J. Biol. Chem. 289, 7835–7843.
25. Crooks D. R., Ghosh M. C., Braun-Sommargren M., Rouault T. A. and Smith D. R. (2007) Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells. J. Neurosci. Res. 85, 1797–1809.
26. Duce J. A., Tsatsanis A., Cater M. A. et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857–867.
27. Dwane S., Durack E. and Kiely P. A. (2013) Optimising parameters for the differentiation of SH-SY5Y cells to study cell adhesion and cell migration. BMC Res. Notes 6, 366.
28. Fan Y., Yamada T., Shimizu T., Nanashima N., Akita M., Suto K. and Tsuchida S. (2009) Ferritin expression in rat hepatocytes and Kupffer cells after lead nitrate treatment. Toxicol. Pathol. 37, 209–217.
29. Goforth J. B., Anderson S. A., Nizzi C. P. and Eisenstein R. S. (2010) Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy. RNA 16, 154–169.
30. Gu H., Wei X., Monnot A. D., Fontanilla C. V., Behl M., Farlow M. R., Zheng W. and Du Y. (2011) Lead exposure increases levels of beta-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice. Neurosci. Lett. 490, 16–20.
31. Gunshin H., Allerson C. R., Polycarpou-Schwarz M. et al. (2001) Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett. 509, 309–316.
32. Guo B., Phillips J. D., Yu Y. and Leibold E. A. (1995) Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J. Biol. Chem. 270, 21645–21651.
33. Hahl P., Davis T., Washburn C., Rogers J. T. and Smith A. (2013) Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states. J. Neurochem. 125, 89–101.
34. Hanna-Attisha M., LaChance J., Sadler R. C. and Champney Schnepp A. (2016) Elevated Blood Lead Levels in Children Associated With the Flint Drinking Water Crisis: a Spatial Analysis of Risk and Public Health Response. Am. J. Public Health 106, 283–290.
35. Holladay S. D., Kerr R., Holladay J. P., Meldrum B., Williams S. M. and Gogal R. M. Jr (2014) Persistent increase of blood lead level and suppression of delta-ALAD activity in northern bobwhite quail orally dosed with even a single 2-mm spent lead shot. Arch. Environ. Contam. Toxicol. 63, 421–428.
36. Horowitz B. Z. and Mirkin D. B. (2001) Lead poisoning and chelation in a mother-neonate pair. J. Toxicol. Clin. Toxicol. 39, 727–731.
37. Hunt R. C., Hunt D. M., Gaur N. and Smith A. (1996) Hemopexin in the human retina: protection of the retina against heme-mediated toxicity. J. Cell. Physiol. 168, 71–80.
38. Ibels L. S. and Pollock C. A. (1986) Lead intoxication. Med. Toxicol. 1, 387–410.
39. Jett D. A., Kuhlmann A. C. and Guilarte T. R. (1997) Intrahippocampal administration of lead (Pb) impairs performance of rats in the Morris water maze. Pharmacol. Biochem. Behav. 57, 263–269.
40. Jin L. W., Ninomiya H., Roch J. M., Schubert D., Masliah E., Otero D. A. and Saitoh T. (1994) Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 5461–5470.
41. Jin M., Shepardson N., Yang T., Chen G., Walsh D. and Selkoe D. J. (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl Acad. Sci. USA 108, 5819–5824.
42. 2+ sensing by iron-responsive messenger RNA:repressor complexes weakens binding. J. Biol. Chem. 284, 30122–30128.
43. Khan M. A., Ma J., Walden W. E., Merrick W. C., Theil E. C. and Goss D. J. (2014) Rapid kinetics of iron responsive element (IRE) RNA/iron regulatory protein 1 and IRE-RNA/eIF4F complexes respond differently to metal ions. Nucleic Acids Res. 42, 6567–6577.
44. Kim K. N., Kwon H. J. and Hong Y. C. (2016) Low-level lead exposure and autistic behaviors in school-age children. Neurotoxicology 53, 193–200.
45. Kwong W. T., Friello P. and Semba R. D. (2004) Interactions between iron deficiency and lead poisoning: epidemiology and pathogenesis. Sci. Total Environ. 330, 21–37.
46. Lahiri D. K., Ge Y. W. and Maloney B. (2005) Characterization of the APP proximal promoter and 5′-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. Faseb J. 19, 653–655.
47. Lahiri D. K., Maloney B. and Zawia N. H. (2009) The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol. Psychiatry 14, 992–1003.
48. Lei P., Ayton S., Finkelstein D. I. et al. (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291–295.
49. Lin J. J., Daniels-McQueen S., Patino M. M., Gaffield L., Walden W. E. and Thach R. E. (1990) Derepression of ferritin messenger RNA translation by hemin in vitro. Science 247, 74–77.
50. Liu J. T., Chen B. Y., Zhang J. Q., Kuang F. and Chen L. W. (2015) Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFkappaB signaling cascades. Toxicol. Lett. 239, 97–107.
51. Mahaffey K. R. (1974) Nutritional factors and susceptibility to lead toxicity. Environ. Health Perspect. 7, 107–112.
52. Maloney B., Ge Y. W., Greig N. and Lahiri D. K. (2004) Presence of a “CAGA box” in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease. FASEB J. 18, 1288–1290.
53. Martelli A. and Moulis J. M. (2004) Zinc and cadmium specifically interfere with RNA-binding activity of human iron regulatory protein 1. J. Inorg. Biochem. 98, 1413–1420.
54. Masters S., Parks J., Atassi A. and Edwards M. A. (2016a) Distribution system water age can create premise plumbing corrosion hotspots. Environ. Monit. Assess. 187, 559.
55. Masters S., Parks J., Atassi A. and Edwards M. A. (2016b) Inherent variability in lead and copper collected during standardized sampling. Environ. Monit. Assess. 188, 177.
56. McCarthy R. C. and Kosman D. J. (2014) Mechanistic analysis of iron accumulation by endothelial cells of the BBB. Biometals 25, 665–675.
57. McCarthy R. C., Park Y. H. and Kosman D. J. (2014) sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 15, 809–815.
58. Mills E., Dong X. P., Wang F. and Xu H. (2010) Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med. Chem. 2, 51–64.
59. Mitchell R. M., Lee S. Y., Randazzo W. T., Simmons Z. and Connor J. R. (2009) Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. J. Neuroinflammation 6, 6.
60. Molina R. M., Phattanarudee S., Kim J., Thompson K., Wessling-Resnick M., Maher T. J. and Brain J. D. (2011) Ingestion of Mn and Pb by rats during and after pregnancy alters iron metabolism and behavior in offspring. Neurotoxicology 32, 413–422.
61. Nagy E., Eaton J. W., Jeney V. et al. (2010) Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 30, 1347–1353.
62. Needleman H. (2004) Lead poisoning. Annu. Rev. Med. 55, 209–222.
63. Ohmori S., Harada K., Wei C. N., Wei Q. and Ueda A. (2006) Effect of estradiol on heme biosynthetic pathway in lead-poisoned rabbits. Environ. Health Prev. Med. 11, 277–285.
64. Olympio K. P., Goncalves C., Gunther W. M. and Bechara E. J. (2009) Neurotoxicity and aggressiveness triggered by low-level lead in children: a review. Rev. Panam. Salud Publica 26, 266–275.
65. Rahman A., Khan K. M., Al-Khaledi G., Khan I. and Attur S. (2014) Early postnatal lead exposure induces tau phosphorylation in the brain of young rats. Acta Biol. Hung. 63, 411–425.
66. Rai N. K., Ashok A., Rai A., Tripathi S., Nagar G. K., Mitra K. and Bandyopadhyay S. (2013) Exposure to As, Cd and Pb-mixture impairs myelin and axon development in rat brain, optic nerve and retina. Toxicol. Appl. Pharmacol. 273, 242–258.
67. Reznichenko L., Amit T., Zheng H., Avramovich-Tirosh Y., Youdim M. B., Weinreb O. and Mandel S. (2006) Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. J. Neurochem. 97, 527–536.
68. Robb S. J., Robb-Gaspers L. D., Scaduto R. C. Jr, Thomas A. P. and Connor J. R. (1999) Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J. Neurosci. Res. 55, 674–686.
69. Rogers J. T. (1996) Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 87, 2525–2537.
70. Rogers J. T. and Lahiri D. K. (2004) Metal and inflammatory targets for Alzheimer's disease. Curr. Drug Targets 5, 535–551.
71. Rogers J. T., Leiter L. M., McPhee J., Cahill C. M., Zhan S. S., Potter H. and Nilsson L. N. (1999) Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274, 6421–6431.
72. Rogers J. T., Randall J. D., Cahill C. M. et al. (2002) An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 45518–45528.
73. Rouault T. A. and Cooperman S. (2006) Brain iron metabolism. Semin. Pediatr. Neurol. 13, 142–148.
74. Schauder A., Avital A. and Malik Z. (2013) Regulation and gene expression of heme synthesis under heavy metal exposure–review. J. Environ. Pathol. Toxicol. Oncol. 29, 137–158.
75. Seo Y. A. and Wessling-Resnick M. (2015) Ferroportin deficiency impairs manganese metabolism in flatiron mice. FASEB J. 29, 2726–2733.
76. Seo Y. A., Li Y. and Wessling-Resnick M. (2013) Iron depletion increases manganese uptake and potentiates apoptosis through ER stress. Neurotoxicology 38, 67–73.
77. Shih R. A., Hu H., Weisskopf M. G. and Schwartz B. S. (2007) Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ. Health Perspect. 115, 483–492.
78. Stangle D. E., Smith D. R., Beaudin S. A., Strawderman M. S., Levitsky D. A. and Strupp B. J. (2007) Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Environ. Health Perspect. 115, 201–209.
79. Stewart P. W., Blaine C., Cohen M., Burright R. G. and Donovick P. J. (1996) Acute and longer term effects of meso-2,3 dimercaptosuccinic acid (DMSA) on the behavior of lead-exposed and control mice. Physiol. Behav. 59, 849–855.
80. Sung L., Shibata M., Eskew J. D., Shipulina N., Morales P. J. and Smith A. (2000) Cell-surface events for metallothionein-1 and heme oxygenase-1 regulation by the hemopexin-heme transport system. Antioxid. Redox Signal. 2, 753–765.
81. Tenopoulou M., Kurz T., Doulias P. T., Galaris D. and Brunk U. T. (2007) Does the calcein-AM method assay the total cellular ‘labile iron pool’ or only a fraction of it? Biochem. J. 403, 261–266.
82. Thomson A. M., Rogers J. T. and Leedman P. J. (1999) Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int. J. Biochem. Cell Biol. 31, 1139–1152.
83. Thomson A. M., Rogers J. T. and Leedman P. J. (2000) Thyrotropin-releasing hormone and epidermal growth factor regulate iron- regulatory protein binding in pituitary cells via protein kinase C-dependent and -independent signaling pathways [In Process Citation]. J. Biol. Chem. 275, 31609–31615.
84. Thomson A. M., Cahill C. M., Cho H. H., Kassachau K. D., Epis M. R., Bridges K. R., Leedman P. J. and Rogers J. T. (2005) The Acute Box cis-Element in Human Heavy Ferritin mRNA 5′-Untranslated Region Is a Unique Translation Enhancer That Binds Poly(C)-binding Proteins. J. Biol. Chem. 280, 30032–30045.
85. Thurtle N., Greig J., Cooney L. et al. (2015) Description of 3180 courses of chelation with dimercaptosuccinic acid in children
86. Tibodeau J. D., Fox P. M., Ropp P. A., Theil E. C. and Thorp H. H. (2006) The up-regulation of ferritin expression using a small-molecule ligand to the native mRNA. Proc. Natl Acad. Sci. USA 103, 253–257.
87. Venkataramani V., Rossner C., Iffland L., Schweyer S., Tamboli I. Y., Walter J., Wirths O. and Bayer T. A. (2010) Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J. Biol. Chem. 285, 10678–10689.
88. Venkataramani V., Thiele K., Behnes C. L. et al. (2012) Amyloid precursor protein is a biomarker for transformed human pluripotent stem cells. Am. J. Pathol. 180, 1636–1652.
89. Verstraeten S. V., Aimo L. and Oteiza P. I. (2008) Aluminium and lead: molecular mechanisms of brain toxicity. Arch. Toxicol. 82, 789–802.
90. Walden W. E., Selezneva A. I., Dupuy J., Volbeda A., Fontecilla-Camps J. C., Theil E. C. and Volz K. (2006) Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA. Science 314, 1903–1908.
91. Wang J. and Pantopoulos K. (2011) Regulation of cellular iron metabolism. Biochem. J. 434, 365–381.
92. Wang W., Di X., D'Agostino R. B. Jr, Torti S. V. and Torti F. M. (2007) Excess capacity of the iron regulatory protein system. J. Biol. Chem. 282, 24650–24659.
93. Wang Q., Lin Y., Zhang W., Liu M., Chen Y., Chen J. and Luo W. (2012) Lead induces dysregulation of iron regulatory protein 1 via the extracellular signal-regulated kinase pathway in human vascular endothelial cells. Brain Res. 1455, 19–27.
94. Winneke G., Lilienthal H. and Kramer U. (1996) The neurobehavioural toxicology and teratology of lead. Arch. Toxicol. Suppl. 18, 57–70.
95. Wirbisky S. E., Weber G. J., Lee J. W., Cannon J. R. and Freeman J. L. (2014) Novel dose-dependent alterations in excitatory GABA during embryonic development associated with Lead (Pb) neurotoxicity. Toxicol. Lett. 229, 1–8.
96. Wong B. X., Tsatsanis A., Lim L. Q., Adlard P. A., Bush A. I. and Duce J. A. (2014) beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE 9, e114174.
97. Zhang F., Wang W., Tsuji Y., Torti S. V. and Torti F. M. (2008) Post-transcriptional modulation of iron homeostasis during P53-dependent growth arrest. J. Biol. Chem. 283, 33911–33918.
98. Zhou F., Chen Y., Fan G. et al. (2014) Lead-induced iron overload and attenuated effects of ferroportin 1 overexpression in PC12 cells. Toxicol. In Vitro 28, 1339–1348.
99. Zhu G., Fan G., Feng C. et al. (2013) The effect of lead exposure on brain iron homeostasis and the expression of DMT1/FP1 in the brain in developing and aged rats. Toxicol. Lett. 216, 108–123.